Sanofi is working on a CEO succession plan in agreement and consultation with current CEO Olivier Brandicourt, Reuters’ Matthias Blamont reports, citing a spokesperson for the drugmaker. Sanofi has an age limit of 65 for its CEO and Brandicourt will be 65 in February 2021, Blamont notes. A Sanofi spokesman commented that “IIt is the responsibility of any company’s board of directors to consider and plan for the succession of its CEO and executive committee members by identifying the next set of future leaders… With this perspective, the board has been considering this succession plan for some time now, in agreement and consultation with our CEO
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.